262 related articles for article (PubMed ID: 17485339)
1. Hepatic knockdown of stearoyl-CoA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid composition.
Xu H; Wilcox D; Nguyen P; Voorbach M; Smith H; Brodjian S; Suhar T; Reilly RM; Jacobson PB; Collins CA; Landschulz K; Surowy TK
Front Biosci; 2007 May; 12():3781-94. PubMed ID: 17485339
[TBL] [Abstract][Full Text] [Related]
2. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of hepatic stearoyl-CoA desaturase-1 expression by fucoxanthin via leptin signaling in diabetic/obese KK-A(y) mice.
Beppu F; Hosokawa M; Yim MJ; Shinoda T; Miyashita K
Lipids; 2013 May; 48(5):449-55. PubMed ID: 23516000
[TBL] [Abstract][Full Text] [Related]
4. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation.
Dobrzyń A; Dobrzyń P
J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():31-42. PubMed ID: 17242489
[TBL] [Abstract][Full Text] [Related]
5. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios.
Peter A; Cegan A; Wagner S; Lehmann R; Stefan N; Königsrainer A; Königsrainer I; Häring HU; Schleicher E
Clin Chem; 2009 Dec; 55(12):2113-20. PubMed ID: 19850634
[TBL] [Abstract][Full Text] [Related]
6. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
Dobrzyn A; Ntambi JM
Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
[TBL] [Abstract][Full Text] [Related]
7. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
Jiang G; Li Z; Liu F; Ellsworth K; Dallas-Yang Q; Wu M; Ronan J; Esau C; Murphy C; Szalkowski D; Bergeron R; Doebber T; Zhang BB
J Clin Invest; 2005 Apr; 115(4):1030-8. PubMed ID: 15761499
[TBL] [Abstract][Full Text] [Related]
8. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver.
Dobrzyn P; Dobrzyn A; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6409-14. PubMed ID: 15096593
[TBL] [Abstract][Full Text] [Related]
9. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice.
Flowers JB; Rabaglia ME; Schueler KL; Flowers MT; Lan H; Keller MP; Ntambi JM; Attie AD
Diabetes; 2007 May; 56(5):1228-39. PubMed ID: 17369521
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of murine SCD4, a novel heart-specific stearoyl-CoA desaturase isoform regulated by leptin and dietary factors.
Miyazaki M; Jacobson MJ; Man WC; Cohen P; Asilmaz E; Friedman JM; Ntambi JM
J Biol Chem; 2003 Sep; 278(36):33904-11. PubMed ID: 12815040
[TBL] [Abstract][Full Text] [Related]
11. SCD1 is nutritionally and spatially regulated in the intestine and influences systemic postprandial lipid homeostasis and gut-liver crosstalk.
Burchat N; Akal T; Ntambi JM; Trivedi N; Suresh R; Sampath H
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Sep; 1867(9):159195. PubMed ID: 35718096
[TBL] [Abstract][Full Text] [Related]
12. Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha.
Miyazaki M; Dobrzyn A; Sampath H; Lee SH; Man WC; Chu K; Peters JM; Gonzalez FJ; Ntambi JM
J Biol Chem; 2004 Aug; 279(33):35017-24. PubMed ID: 15180999
[TBL] [Abstract][Full Text] [Related]
13. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans.
Peter A; Cegan A; Wagner S; Elcnerova M; Königsrainer A; Königsrainer I; Häring HU; Schleicher ED; Stefan N
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E321-6. PubMed ID: 21045174
[TBL] [Abstract][Full Text] [Related]
14. Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice.
Dobrzyn P; Dobrzyn A; Miyazaki M; Ntambi JM
J Lipid Res; 2010 Aug; 51(8):2202-10. PubMed ID: 20363835
[TBL] [Abstract][Full Text] [Related]
15. Distinct correlations between lipogenic gene expression and fatty acid composition of subcutaneous fat among cattle breeds.
Gamarra D; Aldai N; Arakawa A; Barron LJR; López-Oceja A; de Pancorbo MM; Taniguchi M
BMC Vet Res; 2018 May; 14(1):167. PubMed ID: 29792205
[TBL] [Abstract][Full Text] [Related]
16. Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice.
Hu CC; Qing K; Chen Y
Obes Res; 2004 Aug; 12(8):1264-70. PubMed ID: 15340109
[TBL] [Abstract][Full Text] [Related]
17. Vitamin A regulates obesity in WNIN/Ob obese rat; independent of stearoyl-CoA desaturase-1.
Jeyakumar SM; Vajreswari A; Giridharan NV
Biochem Biophys Res Commun; 2008 May; 370(2):243-7. PubMed ID: 18364238
[TBL] [Abstract][Full Text] [Related]
18. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet.
Kuda O; Stankova B; Tvrzicka E; Hensler M; Jelenik T; Rossmeisl M; Flachs P; Kopecky J
J Physiol Pharmacol; 2009 Dec; 60(4):135-40. PubMed ID: 20065507
[TBL] [Abstract][Full Text] [Related]
19. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans.
Stefan N; Peter A; Cegan A; Staiger H; Machann J; Schick F; Claussen CD; Fritsche A; Häring HU; Schleicher E
Diabetologia; 2008 Apr; 51(4):648-56. PubMed ID: 18286258
[TBL] [Abstract][Full Text] [Related]
20. Loss of ULK1 increases RPS6KB1-NCOR1 repression of NR1H/LXR-mediated Scd1 transcription and augments lipotoxicity in hepatic cells.
Sinha RA; Singh BK; Zhou J; Xie S; Farah BL; Lesmana R; Ohba K; Tripathi M; Ghosh S; Hollenberg AN; Yen PM
Autophagy; 2017 Jan; 13(1):169-186. PubMed ID: 27846372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
